Oxford Biomedica PLC Sustainability Reports
Oxford Biomedica plc operates as a pure-play contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. The company provides process development and manufacturing services for viral vectors including lentivirus, adeno-associated virus, and adenoviral vectors.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange
LEI: 213800S1GVQNXQ15K851
FIGI: BBG001S9D985
15 reports from 2011 to 2025
